Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
[SIDMOOL] INFLAX Pore Control Ampoule 60ml | Shopee Malaysia
INFLAX от грибка. КУПИТЬ гель, отзывы, цена в Германии?
DORNAC INFLAX 30CPS BIONATUS 1295466 | Droga Raia
Inflax Reviews, Price, How To Use, Effects 2025
Dornac Inflax Bionatus - 30 cápsulas - O Alquimista
Sidmool Inflax Pore Control Ampoule ingredients (Explained)
Dornac Inflax 30 Cápsulas - Bionatus - Extrafarma
Inflax - ttgt - CARRERA DE LABORATORIO CLÍNICO Inmunología y ...
Inflax натуральный гель от грибка и псориаза (Инфлакс) (ID#2182925121 ...
Купить ⭕ Inflax - быстрое лечение и профилактика грибка ногтей и стоп в ...
Preço de Inflax 20 Mg Com 8 Comprimidos nas melhores farmácias
Kit Dornac Inflax Bionatus Com 3 Caixas De 30 Cápsulas Cada Sem Sabor ...
INFLAX GEL ANTI DOULEURS 120ML
InflaRx attracts strong investor interest with US share offering ...
InflaRx Investor Update: Izicopan Set to Take Center Stage in AAV and ...
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis ...
InflaRx Pulls Off $150 Million Capital Raise as Pipeline Pivot Gathers Pace
InflaRx stock surges on AAV drug development plan By Investing.com
InflaRx N.V. (IFRX) Regains Compliance With Nasdaq
InflaRx prices $150M offering of ordinary shares
Top 5 Hot Penny Stocks to Buy Now - Insider Monkey
Biotech surges as big money backs high-stakes kidney disease push
InflaRx Q1 2026 earnings preview
InflaRx完成1.5亿美元股票发行，发行价为每股$2.00 提供者 Investing.com
InflaRx (IFRX) Is Up 17.7% After INF904 Shows Promising Results in ...
InflaRx entwickelt Wirkstoff Izicopan zur Behandlung von ...
InflaRx NV sell Wolf_of_WS
InflaRx (IFRX) Loses -15.29% in 4 Weeks, Here's Why a Trend Reversal ...
April 2026 Penny Stocks To Watch For Potential Growth
InflaRx: 150 Millionen Dollar Kapitalerhöhung
InflaRx wird zur Biotech-Wette
InflaRx: 150 Millionen für Izicopan-Entwicklung
InflaRx COVID injection gets US FDA's emergency-use authorization, ET ...
WuXi Biologics Partners with InflaRx to Advance Gohibic for Critically ...
InflaRx announces a $55M Series D financing and investment round to ...
InflaRx completes enrolment in Phase IIb hidradenitis suppurativa trial
InflaRx may find path forward for COVID drug in skin disorder
InflaRx Stock: Gohibic Flops, INF904 Underwhelms, Cash Burn Accelerates ...
InflaRx’s Oral Drug INF904 Shows Promising Phase 2 Results in Two Skin ...
Inflarx (IFRX) Investor Presentation - Slideshow (NASDAQ:IFRX ...
InflaRx Discontinues Pyoderma Gangrenosum Trial, Shifts Focus to INF904 ...
InflaRx N.V. (IFRX) Discusses Topline Phase 2a Data in Chronic ...
InflaRx (IFRX) Stock Up on FDA's EUA for COVID-19 Treatment
Why InflaRx N.V. Stock Is Poised For A Rebound?
InflaRx Set to Reveal 2024 Results and Join Investor Events - Investors ...
InflaRx Axes Rare Skin Disease Study on Disappointing Late-Stage Data ...
InflaRx Cuts Costs: 30% Workforce Reduction and Shift in Focus ...
InflaRx to Reveal Phase 2a Clinical Trial Data Amid Q3 2025 Financials
InflaRx Provides Update on Phase 3 Data Analyses for
InflaRX jumps 60% On FDA emergency approval of Gohibic for Covid-19 ...
InflaRx targets key data readouts for INF904 in skin conditions ...
US FDA grants EUA to InflaRx’s Covid-19 treatment
Inflarx N.V. (IFRX) Stock: Climbs 2.5% Ahead of Key Phase 2a Data Release
InflaRx Targets Uncommon Skin Disorder Research Following Underwhelming ...
InflaRx seeks US FDA authorisation for Covid-19 treatment
InflaRx outlines data analyses of Phase 3 study for vilobelimab in PG
InflaRx's Mysterious 12.6% Surge: What’s Driving the Spike?
InflaRx Faces Nasdaq Listing Challenge; Analysts Predict 382% Upside
What's Going On With InflaRx Stock Monday? - InflaRx (NASDAQ:IFRX ...
InflaRx Soar after Amending COVID-19 Treatment Agreement - TipRanks.com
InflaRx Announces Positive Phase 2a Results for INF904 in HS and CSU ...
15 Mar Inflarx Logo - Inflarx Nv Logo - Free Transparent PNG Download ...
InflaRx Stanches Spending With 30% Staff Reduction, Priority Pivot ...
Germany’s InflaRx, China's Staidson Agree on Covid-19 Drug Sales
InflaRx's 58.9% Plunge: Technical Sell-off or Hidden Catalyst?
InflaRx to Announce Phase 2a INF904 Data in HS and CSU Nov 10 | IFRX ...
InflaRx wins EU approval for Gohibic in Covid-19-induced ARDS
InflaRx Is Not Worth Chasing Following Emergency Use Authorization ...
InflaRx gets EU okay for Gohibic for COVID-19 respiratory distress
InflaRx Ends Lead Asset Development After Failed Study For Rare And ...
InflaRx reports positive phase 2 results for HS and CSU treatments - PMLiVE
inflarx.sharepoint.com - Sign in to your account
InflaRx Advances INF904 for CSU and HS with Phase 2a Study ...
Reining in Inflammation to Treat ARDS | The Scientist
InflaRx Announces Topline Phase 2a Data for INF904 Trial
InflaRx Launches Gohibic in US to Treat Critically Ill COVID-19 ...
InflaRx's Mysterious 17% Surge: A Deep-Dive into the Unexplained Spike
InflaRx raises $30 million in public offering | Biotechnology | The ...
InflaRx (IFRX) details Phase 3 post-hoc data in PG | IFRX Stock News
Prof. Dr. Niels Riedemann — CEO, InflaRx — Controlling Life Threatening ...
Guggenheim Upgrades InflaRx N.V. (IFRX) | Nasdaq
InflaRx (IFRX) Skyrockets 110% in Six Months: Here's Why | Nasdaq
InflaRx Navigates Clinical Crossroads: Can Upcoming Data Turn the Tide?
BioCentury - Inflarx drops lead program targeting C5a in rare skin disorder
China’s WuXi Biologics to Make German Biopharma Firm InflaRx’s Covid-19 ...
InflaRx Aims for $100M IPO to Support Anti-Inflammatory Drug Development
InflaRx charts layoffs, cost cuts to lift lead asset's prospects
Positive CHMP opinion for Gohibic (vilobelimab) for the treatment of ...
Forget Humira, InflaRx Has a New Inflammation Treatment on the Horizon
InflaRx Plummets 60%: A Deep Dive into the Technical Sell-Off
InflaRx drops rare skin disease study for COVID med vilobelimab after ...
InflaRx Gets Nasdaq Notice Over $1 Minimum Bid Price Requirement | IFRX ...
INFLAX: Innovación en Sillones Envasados al Vacío by Ludmila Gallardo ...
InflaRx (IFRX): Strong Industry, Solid Earnings Estimate Revisions
Is InflaRx NV Gaining or Losing Market Support? - InflaRx (NASDAQ:IFRX ...
InflaRx's 60% Plunge: Technical Triggers and Order Flow Mayhem
Inflax: Крем, Цена, Отзывы, Ингредиенты, раР...
Inflarx flexes; HS, CSU continue to percolate | BioWorld
InflaRx plans to launch Covid antibody with five-figure price tag : r ...
InflaRx NV Stock Quote IFRX - Stock Price, News, Charts, Message Board ...
InflaRx Profile | The Scientist
InflaRx Halts Development of Gohibic: What You Need to Know About the ...
InflaRx N.V. - InflaRx - virtual R&D event INF904: oral C5aR inhibitor ...
InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in ...
Infralax EMS 15 Comprimidos
Inflax: креме, Цена, Отзывы, Ингредиенты, рР...
A Comprehensive Review of Cross-Linked Gels as Vehicles for Drug ...
FDA Gives InflaRx’s Anti-Inflammation Drug the Green Light - Life ...
InflaRx launches emergency Covid-19 treatment in the US - Drug ...
INFRALAX - PARA QUE SERVE, COMO FUNCIONA, COMO TOMAR, EFEITOS ...
InflaRx Raises $100 Million in IPO - Global Genes
